Combination immunotherapy approaches (Q38037492)

1 July 2019

title

Combination immunotherapy approaches (English)

1 reference

1 July 2019

1 reference

C G Drake

1

1 reference

1 July 2019

publication date

1 September 2012

1 reference

1 July 2019

published in

Annals of Oncology

1 reference

1 July 2019

volume

23 Suppl 8

1 reference

1 July 2019

page(s)

viii41-6

1 reference

1 July 2019

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Immune surveillance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Dual roles of immune cells and their factors in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

The anticancer immune response: indispensable for therapeutic success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Systemic effects of local radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Prostate cancer as a model for tumour immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

T cells take aim at cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

The TIM gene family regulates autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

CTLA-4: negative regulator of the immune response and a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Enhancing immune responses to tumor-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Inflammation and cancer: a double-edged sword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS262

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

21 January 2018

1 reference

12 December 2020

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

1 reference

12 December 2020

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

1 reference

12 December 2020

T-cell costimulation--biology, therapeutic potential, and challenges

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDS262

1 reference

1 July 2019

PMCID

6278955

1 reference

1 July 2019

PubMed ID

22918927

1 reference

1 July 2019